In Conversation

"In the context of the Colombian medical devices landscape as a whole, one of the key developments within the last four years is the country’s participation…

"Even with our combined 20 years’ experience in the pharmaceutical industry working in large multinational companies, we would have never have imagined back then that Astro…

"[Digitalization] is a crucial area to invest and demonstrate presence in as it will be indispensable for the healthcare systems of the future"

"We are in the process of evolving our communications approach to be more open and proactive."

"One reason we have been able to build such a positive image within the market so quickly is Accord’s innovative system of chain supply management."

"In the past, we did a lot of transactional work with our clients but these days, we are a lot more focused on regulatory and compliance…

"All in all, it is a balancing act. We must find the equilibrium between drug prices, which have risen drastically in several therapeutic areas in the…

"The idea is to provide an integrated healthcare provision system that allows the patient to move more fluidly from home to hospital and back. The goal…

"We must work together and acknowledge that the price of a medicine reflects its impact for patients, economy and the society, especially when the therapy leads…

"I appreciate the country’s political and economic stability, if compared to its peers in Latin America, its potential growth, and the quality and preparation of people."

"Austria is the third largest phytotherapeutic market in Europe behind Germany and Switzerland in the Schwabe group."

"One advantage of Hong Kong is the beauty of its small size, so it is possible for me to communicate directly with my team."

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here